Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,066,371 papers from all fields of science
Search
Sign In
Create Free Account
Osteoporosis
Known as:
OSTEOPOROSE
, Osteoporosis [Disease/Finding]
, Osteoporoses
Expand
A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2
Bone Demineralization, Pathologic
Bruck syndrome 1
CALCA gene
Expand
Broader (1)
Metabolic Bone Disorder
Narrower (5)
Osteoporosis, Postmenopausal
Osteoporotic Fractures
TRANSIENT REGIONAL OSTEOPOROSIS
Winchester syndrome (disorder)
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Wnt/beta-catenin signaling: components, mechanisms, and diseases.
B. MacDonald
,
K. Tamai
,
Xi He
Developmental Cell
2009
Corpus ID: 12218983
Highly Cited
2009
Highly Cited
2009
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
S. Cummings
,
J. S. San Martin
,
+13 authors
C. Christiansen
New England Journal of Medicine
2009
Corpus ID: 9387481
BACKGROUND Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear factor-kappaB ligand (RANKL) that…
Expand
Highly Cited
2007
Highly Cited
2007
Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025
R. Burge
,
B. Dawson-Hughes
,
D. Solomon
,
J. Wong
,
Alison B King
,
A. Tosteson
Journal of Bone and Mineral Research
2007
Corpus ID: 24212206
This study predicts the burden of incident osteoporosis‐related fractures and costs in the United States, by sex, age group, race…
Expand
Highly Cited
2007
Highly Cited
2007
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
D. Black
,
P. Delmas
,
+18 authors
S. Cummings
New England Journal of Medicine
2007
Corpus ID: 28499215
BACKGROUND A single infusion of intravenous zoledronic acid decreases bone turnover and improves bone density at 12 months in…
Expand
Review
2005
Review
2005
Pathogenesis of osteoporosis: concepts, conflicts, and prospects.
L. Raisz
Journal of Clinical Investigation
2005
Corpus ID: 44866778
Osteoporosis is a disorder in which loss of bone strength leads to fragility fractures. This review examines the fundamental…
Expand
Highly Cited
2004
Highly Cited
2004
Grading quality of evidence and strength of recommendations
D. Atkins
,
D. Best
,
+24 authors
S. Zaza
BMJ : British Medical Journal
2004
Corpus ID: 15294874
Abstract Users of clinical practice guidelines and other recommendations need to know how much confidence they can place in the…
Expand
Review
2001
Review
2001
Osteoporosis prevention, diagnosis, and therapy.
A. Klibanski
,
L. Adams-Campbell
,
+10 authors
W. Russell
JAMA
2001
Corpus ID: 33110225
OBJECTIVES To clarify the factors associated with prevention, diagnosis, and treatment of osteoporosis, and to present the most…
Expand
Highly Cited
1998
Highly Cited
1998
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
N. Bucay
,
I. Sarosi
,
+9 authors
W. S. Simonet
Genes & Development
1998
Corpus ID: 44861000
Osteoprotegerin (OPG) is a secreted protein that inhibits osteoclast formation. In this study the physiological role of OPG is…
Expand
Highly Cited
1997
Highly Cited
1997
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
W. S. Simonet
,
D. Lacey
,
+27 authors
W. Boyle
Cell
1997
Corpus ID: 12162262
Highly Cited
1992
Highly Cited
1992
The diagnosis of osteoporosis
J. Kanis
,
L. J. Melton
,
C. Christiansen
,
C. Johnston
,
N. Khaltaev
Southern medical journal (Birmingham, Ala. Print)
1992
Corpus ID: 5350563
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE